Regulus Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Regulus Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Regulus Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Regulus Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $869 | 302 | 2.88 |
2023-12-31 | $430 | 344 | 1.25 |
2023-09-30 | $543 | 408 | 1.33 |
2023-06-30 | $5.4k | 3.6k | 1.50 |
2023-03-31 | $1.4k | 1.7k | 0.83 |
2022-12-31 | $7.8k | 5.7k | 1.37 |
2022-09-30 | $17k | 10k | 1.67 |
2022-06-30 | $17k | 8.3k | 2.06 |